找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Omics for Personalized Medicine; Debmalya Barh,Dipali Dhawan,Nirmal Kumar Ganguly Book 2013 Springer India 2013 Genotype.Nutrition.Pharmac

[复制链接]
楼主: 僵局
发表于 2025-3-23 13:31:55 | 显示全部楼层
g on the development of personalized medicine in several areas of human health. The topics covered range from metabolic and neurological disorders to non-communicable as well as infectious diseases, and even ex978-81-322-2876-9978-81-322-1184-6
发表于 2025-3-23 15:03:07 | 显示全部楼层
发表于 2025-3-23 21:05:55 | 显示全部楼层
发表于 2025-3-24 02:05:18 | 显示全部楼层
Melvin George MD., DM.,Sandhiya Selvarajan,Suresh Kumar Srinivasamurthy
发表于 2025-3-24 05:00:13 | 显示全部楼层
发表于 2025-3-24 06:47:14 | 显示全部楼层
发表于 2025-3-24 13:42:17 | 显示全部楼层
Next-Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Meng technology. NGS is revolutionizing pharmacogenomics and personalized medicine, with several NGS platforms commercially available. Illumina, Roche 454, and Applied Biosystems are the current major vendors. This chapter will characterize the technical assessments of NGS, including comparative analy
发表于 2025-3-24 18:41:20 | 显示全部楼层
发表于 2025-3-24 21:32:37 | 显示全部楼层
Omics Approaches and Applications in Clinical Trialsce of severe drug reactions and better clinical outcome in susceptible patients, is one of the few examples of use of genomics in the area of health care. Pharmacogenomics identifies safety biomarkers and provides an opportunity to rescue a compound that would otherwise fail to be commercialized due
发表于 2025-3-25 00:59:16 | 显示全部楼层
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-6-22 10:20
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表